CEO of a Newly Expanded J. Craig Venter Institute to Speak at SEQNSYNTECH

Craig Venter became president and CEO of a newly expanded J. Craig Venter Institute after it absorbed the Institute for Genomic Research and the J. Craig Venter Science Foundation.

Venter will be president and chief executive officer of the combined institute. Claire Fraser-Liggett will stay on as president of TIGR and Robert Strausberg, group leader of human genome medicine at the Venter Institute, will become president of the Center for the Advancement of Genomics, which was renamed from JCVI, according to the memo. TIGR and TCAG will be divisions of the Venter Institute.

Venter is one of the leading scientists of the 21st century for his visionary contributions in genomic research.

Select Biosciences have announced this week that Craig Venter will be presenting as a plenary speaker at their inaugural conference designed to review Advances in Nucleic Acid Synthesis & Sequencing, SEQNSYNTECH 15 - 16 May 2007, Edinburgh, Scotland.

The first meeting will be held in Edinburgh, close to Scotland’s growing biotech community, universities and research institutions.

SEQNSYNTECH is one of 3 co-located meetings centered on genomics and drug research. The others are the Lab-on-a-Chip World Congress and Advances in Microarray Technology.